Clinical Trial Update: Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)

View source ↗

Summary

This clinical trial update reports safety findings from the ZIP 3000 study evaluating ZyComb in patients with the common cold. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• ZyComb

Snippet

Sponsor: Nycomed | Conditions: Common Cold | Status: COMPLETED